| |
|
|
|
Galectin Therapeutic
|
|
2.66 +0.17 (+6.83%) |
10/20/2017 3:59pm |
|
Open: |
2.55 |
Pre close: |
2.49 |
Target:
|
3.39
|
|
High: |
2.78 |
Low: |
2.51 |
Resistance:
|
2.90
3.39
|
|
Volume: |
388,165 |
Market Cap: |
93.24M |
Support:
|
2.12
 1.64
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.45
|
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
2.43 |
Signal(12,26,9): |
0.16  |
|
MA(100): |
2.16 |
Stochastic Oscillator |
%K(14,3):
|
59.70 |
|
MA(250): |
1.86 |
%D(3): |
50.17 |
|
Average Volume(K) |
3-Month: |
17602
|
52-Week |
High:
|
3.68 |
|
10-Days: |
13972 |
Low: |
0.49 |
|
RSI |
RSI(14):
|
62.42 |
Change(%): |
232.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.610 |
Return on Equity (ttm) |
-181.7 |
Shares Out. (M) |
35.00 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-88.3 |
Shares Float (M) |
28.04 |
|
EPS Est. Next Year |
-0.570 |
PEG Ratio |
0.00 |
% Held by Insiders |
22.19 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.06 |
|
Forward EPS |
-0.790 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1150 |
|
Book Value (p.s.) |
-0.090 |
EBITDA (p.s.) |
-0.556 |
P/E |
-4.36 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-29.56 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.17 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.80 |
P/CF |
-5.42 |
|
|
|
|
|
|
|
